Safety and anti-tumor activity of BAY 2927088 in patients with HER2 -mutant NSCLC: Results from an expansion cohort of the SOHO-01 phase I/II study.

Autor: Girard, Nicolas, Kim, Tae Min, Kim, Hye Ryun, Loong, Herbert H., Shinno, Yuki, Lu, Shun, Fang, Yong, Zhao, Jun, Nishino, Kazumi, Lee, Ki Hyeong, Miao, Liyun, Sakamoto, Tomohiro, Felip, Enriqueta, Yang, Tsung-Ying, Dooms, Christophe Alfons, Tan, Daniel Shao-Weng, Le, Xiuning, Brase, Jan Christoph, Grassi, Paolo, Goto, Koichi
Zdroj: Journal of Clinical Oncology; 2024 Supplement 17, Vol. 42, pLBA8598-LBA8598, 83p
Databáze: Supplemental Index